Cardiac radiofrequency ablation is the delivery of an electrode catheter into a specific part of the cardiac cavity through a vein or an artery, and the release of radiofrequency current leads to coagulation necrosis of the local endocardium and subendocardial myocardium, thereby blocking the abnormal conduction beam and origin of tachyarrhythmia. interventional techniques. The damage range of the radiofrequency current introduced into the cardiac cavity through the catheter is 1-3 mm, which will not cause harm to the body. Radiofrequency ablation has become the most effective method for radical treatment of paroxysmal tachycardia. Cardiac RF Ablation Generators are one of the core devices for cardiac radiofrequency ablation.
This report contains market size and forecasts of Cardiac RF Ablation Generators in global, including the following market information:
Global Cardiac RF Ablation Generators Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cardiac RF Ablation Generators Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cardiac RF Ablation Generators companies in 2021 (%)
The global Cardiac RF Ablation Generators market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Max Output RF Power: 50W Below Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cardiac RF Ablation Generators include Biosense Webster (Johnson & Johnson MedTech), Medtronic, BIOTRONIK, Abbott, RF Medical, Philips, Livetec, Boston Scientific and AngioDynamics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cardiac RF Ablation Generators manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiac RF Ablation Generators Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac RF Ablation Generators Market Segment Percentages, by Type, 2021 (%)
Max Output RF Power: 50W Below
Max Output RF Power: 50-100W
Max Output RF Power: 100W Above
Global Cardiac RF Ablation Generators Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac RF Ablation Generators Market Segment Percentages, by Application, 2021 (%)
Hospitals
Medical Research Institute
Others
Global Cardiac RF Ablation Generators Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac RF Ablation Generators Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardiac RF Ablation Generators revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cardiac RF Ablation Generators revenues share in global market, 2021 (%)
Key companies Cardiac RF Ablation Generators sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cardiac RF Ablation Generators sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biosense Webster (Johnson & Johnson MedTech)
Medtronic
BIOTRONIK
Abbott
RF Medical
Philips
Livetec
Boston Scientific
AngioDynamics
Toray Industries
OSYPKA AG
Lifeline
Leading Electorn Technology
Jinjiang Electronic Science and Technology
Microport EP Medtech
Apt Medical Inc.
MedSphere International